Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $646.35 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $264.46 | 13 | $0 (2024) |
| Lundbeck LLC | $171.75 | 8 | $0 (2024) |
| Corium, LLC | $120.95 | 4 | $0 (2024) |
| Axsome Therapeutics, Inc. | $45.77 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.78 | 1 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $21.64 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $274.76 | 12 | Corium, LLC ($91.22) |
| 2023 | $241.77 | 10 | ABBVIE INC. ($123.47) |
| 2022 | $80.59 | 5 | ABBVIE INC. ($80.59) |
| 2021 | $49.23 | 2 | Lundbeck LLC ($49.23) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $33.16 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.01 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.52 | General |
| Category: PSYCHIATRY | ||||||
| 07/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.35 | General |
| Category: PSYCHIATRY | ||||||
| 03/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/23/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/21/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.83 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/15/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.12 | General |
| Category: PSYCHIATRY | ||||||
| 02/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Neuropsychiatry | ||||||
| 01/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 223 | 607 | $120,120 | $42,874 |
| 2022 | 3 | 355 | 822 | $126,775 | $41,829 |
| 2021 | 3 | 540 | 1,088 | $174,775 | $63,528 |
| 2020 | 3 | 516 | 1,071 | $168,175 | $52,385 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 565 | $112,950 | $40,335 | 35.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 13 | $3,250 | $1,064 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 16 | $2,400 | $885.59 | 36.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 13 | $1,520 | $589.52 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 246 | 664 | $99,600 | $32,845 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 99 | $19,800 | $7,190 | 36.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 43 | 59 | $7,375 | $1,794 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 312 | 738 | $110,750 | $39,763 | 35.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 156 | 269 | $53,900 | $21,307 | 39.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 72 | 81 | $10,125 | $2,458 | 24.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 285 | 718 | $107,700 | $33,222 | 30.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 122 | 218 | $43,600 | $15,534 | 35.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 109 | 135 | $16,875 | $3,629 | 21.5% |
About Karen Woods, PMHNP
Karen Woods, PMHNP is a Psychiatric/Mental Health healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2009. The National Provider Identifier (NPI) number assigned to this provider is 1215162094.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Karen Woods, PMHNP has received a total of $646.35 in payments from pharmaceutical and medical device companies, with $274.76 received in 2024. These payments were reported across 29 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($646.35).
As a Medicare-enrolled provider, Woods has provided services to 1,634 Medicare beneficiaries, totaling 3,588 services with total Medicare billing of $200,617. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Fort Myers, FL
- Active Since 05/21/2009
- Last Updated 09/23/2024
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1215162094
Products in Payments
- VRAYLAR (Drug) $264.46
- REXULTI (Drug) $122.52
- Azstarys (Drug) $120.95
- BRINTELLIX (Drug) $49.23
- Auvelity (Drug) $45.77
- TRINTELLIX (Drug) $21.78
- INGREZZA (Drug) $21.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Fort Myers
Dylan Demars, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $19,981
Mrs. Jacqueline Bannister, Arnp, ARNP
Psychiatric/Mental Health — Payments: $10,808
Amanda Boroff, Aprn, APRN
Psychiatric/Mental Health — Payments: $6,632
Ms. Jeanne Jagodzinski, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $3,706
Collin Mcgrath, Dnp, Aprn, Pmhnp, DNP, APRN, PMHNP
Psychiatric/Mental Health — Payments: $3,415
Jennifer Randall, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $3,338